ANNA AIAZZI: Open Payments
NPI 1417597923 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,673 in 167 payments from 17 companies in 2025. Trend: 2023 $4,197 · 2024 $1,822 · 2025 $2,673
Food & beverage: $2,598Education: $75
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 16 | $375 |
| ABBVIE INC. | 22 | $330 |
| Novartis Pharmaceuticals Corporation | 14 | $258 |
| Janssen Biotech, Inc. | 14 | $255 |
| Botanix SB Inc | 31 | $232 |
| Arcutis Biotherapeutics, Inc. | 13 | $173 |
| Lilly USA, LLC | 9 | $170 |
| E.R. Squibb & Sons, L.L.C. | 11 | $162 |
| Amgen Inc. | 7 | $159 |
| Incyte Corporation | 7 | $146 |
Products named: Bimzelx, TREMFYA, SOFDRA, SKYRIZI, COSENTYX, Zoryve, Sotyktu, OTEZLA.
Industry payments across MO — which companies pay providers there.
